Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Dana-Farber Cancer Institute
Study ID
NCT07412041
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • PERCC — BEHAVIORAL
    Personalized at-home exercise program, including aerobic and resistance exercise. Supervised by trained exercise professional via ZOOM (HIPPA complaint video conferencing platform). Study equipment of Fitbit and resistance bands will be provided to participants.

Study Details

The purpose of this study is to test the feasibility of the Precise Exercise Regimen for Cancer Care (PERCC) exercise program in participants with stage II-III primary lung cancer.

Key Dates

First listed
Feb 17, 2026
Start date
Jan 22, 2026
Status verified
Feb 2026
Primary completion
Mar 30, 2027
Completion
Mar 30, 2028

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: PERCC
    Receives personalized virtual exercise program (aerobic and resistance exercise) 1x weekly for patients with lung cancer who plan on receiving neoadjuvant treatment followed by surgery.

Primary Outcome Measure

Attendance of Exercise Sessions (Feasibility) [ Time Frame: From first exercise session to final exercise session (up to 24 weeks) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Dana-Farber Cancer InstituteBostonMassachusetts02215
Christina Dieli-Conwright
[email protected]
617-632-3800

Find similar trials in Boston, MA

Nationwide
Lung cancer trialsOncology trialsLung oncology trialsLung disease trials
By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Dana-Farber Cancer Institute· Boston, MA

Related Studies